FDA approves expanded label for Namzaric in Alzheimer’s disease
20 July 2016 | By Victoria White, Digital Content Producer
The US Food and Drug Administration (FDA) has approved an expanded label for Namzaric.
List view / Grid view
News
First-in-human study of CMV vaccine HB-101 starts
20 July 2016 | By Victoria White, Digital Content Producer
Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus...
APAC osteoporosis market to hit $7.7 billion by 2022, says GBI Research
19 July 2016 | By Victoria White, Digital Content Producer
The Asia-Pacific (APAC) osteoporosis market is set to grow from $4.5 billion in 2015 to $7.7 billion in 2022, according to GBI Research...
Blood cancer study yields disappointing results
19 July 2016 | By Niamh Louise Marriott
Gazyvaro did not meet its primary endpoint of significantly reducing the risk of disease worsening or death in people with diffuse large B-cell lymphoma...
Triumeq demonstrates superior efficacy for treating women with HIV
19 July 2016 | By Victoria White, Digital Content Producer
Triumeq demonstrated superior efficacy compared with ATV/r plus TDF/FTC in 495 treatment-naïve women living with HIV...
Five-year data from Phase II trial of Adcetris published
19 July 2016 | By Victoria White, Digital Content Producer
The data comes from a Phase II trial of Adcetris (brentuximab vedotin) in patients with relapsed or refractory classical Hodgkin lymphoma...
Samsung Bioepis seeks EU approval for its biosimilar adalimumab candidate, SB5
18 July 2016 | By Victoria White, Digital Content Producer
At an estimated $4billion a year, the reference product, Humira, is among the European Union's largest single drug expenditures...
Applications invited to join the NICE Board
15 July 2016 | By National Institute for Health and Care Excellent (NICE)
NICE is advertising for five Non-Executive Directors to help NICE improve outcomes for people using the NHS, public health and social care services...
EC approves Revlimid for mantle cell lymphoma
15 July 2016 | By Victoria White, Digital Content Producer
Celgene’s Revlimid (lenalidomide) has been approved by the EC for the treatment of adult patients with relapsed or refractory mantle cell lymphoma...
First-in-human trial of MundiPharma’s EDO-S101 starts
14 July 2016 | By Victoria White, Digital Content Producer
A first in class, fusion molecule, S101 is currently being developed for the treatment of relapsed-refractory haematological malignances...
FDA committee recommends approval of Sandoz’s biosimilar etanercept
14 July 2016 | By Victoria White, Digital Content Producer
The Arthritis Advisory Committee voted unanimously in support of biosimilar etanercept for all five indications of the reference product...
FDA grants priority review to Janssen’s chewable mebendazole
14 July 2016 | By Victoria White, Digital Content Producer
If approved, chewable mebendazole will provide a treatment and prevention alternative for adults and children with soil-transmitted helminthiasis...
Lilly and Boehringer Ingelheim take on metastatic breast cancer
13 July 2016 | By Victoria White, Digital Content Producer
Lilly and Boehringer Ingelheim are to collaborate on a Phase Ib study of abemaciclib and BI 836845 in patients with HR+, HER2- metastatic breast cancer...
IBD Unmasked – helping to shift perceptions of IBD
13 July 2016 | By Victoria White, Digital Content Producer
Collaborating with Marvel Custom Solutions, Takeda’s IBD Unmasked initiative features an IBD Super Hero, Samarium, and a graphic novel series...
First patient treated in Phase I VXM01 glioblastoma trial
Vaximm's VXM01 is an oral T-cell immunotherapy that targets the tumour-specific vasculature and certain immune-suppressive cells...
